Ambac Financial Group (OSG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
A special meeting is scheduled for October 16, 2024, to vote on the sale of all shares of Ambac Assurance Corporation (AAC) to American Acorn Corporation, owned by Oaktree Capital Management, for $420 million in cash, subject to adjustments.
The board unanimously recommends approval of the sale, an advisory vote on executive compensation related to the sale, and the potential adjournment of the meeting to solicit more votes if needed.
The sale is considered a disposition of substantially all assets under Delaware law and requires approval by a majority of outstanding shares.
Voting matters and shareholder proposals
Shareholders will vote on: (1) the sale of AAC, (2) advisory approval of executive compensation in connection with the sale, and (3) adjournment of the meeting if more votes are needed.
The sale requires a majority of outstanding shares; the compensation and adjournment proposals require a majority of votes cast at the meeting.
The board recommends voting “FOR” all proposals.
Board of directors and corporate governance
The board conducted a thorough review of strategic alternatives, including the sale, and determined the Oaktree offer provided the best value on a time- and risk-adjusted basis.
The board’s decision was supported by a fairness opinion from Moelis & Company.
The board will remain unchanged after the sale, except for a potential director designated by Oaktree if certain warrant conditions are met.
Latest events from Ambac Financial Group
- Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025 - Transformational year with strategic transactions, strong specialty insurance growth, and enhanced governance.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025